Atavistik Bio is a pre-clinical biotechnology company dedicated to discovering and developing innovative therapies for metabolic diseases and cancer. The company focuses on identifying metabolite-protein interactions and harnessing nature's allosteric control mechanisms to create first-in-class drug candidates. By applying its platform to genetically validated targets, Atavistik Bio aims to advance novel treatments that address significant medical needs in these areas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.